These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 13678639

  • 1. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative.
    Hotez PJ, Zhan B, Bethony JM, Loukas A, Williamson A, Goud GN, Hawdon JM, Dobardzic A, Dobardzic R, Ghosh K, Bottazzi ME, Mendez S, Zook B, Wang Y, Liu S, Essiet-Gibson I, Chung-Debose S, Xiao S, Knox D, Meagher M, Inan M, Correa-Oliveira R, Vilk P, Shepherd HR, Brandt W, Russell PK.
    Int J Parasitol; 2003 Sep 30; 33(11):1245-58. PubMed ID: 13678639
    [Abstract] [Full Text] [Related]

  • 2. Experimental approaches to the development of a recombinant hookworm vaccine.
    Hotez PJ, Ghosh K, Hawdon JM, Narasimhan S, Jones B, Shuhua X, Sen L, Bin Z, Haechou X, Hainan R, Heng W, Koski RA.
    Immunol Rev; 1999 Oct 30; 171():163-71. PubMed ID: 10582170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunobiology of hookworm infection.
    Loukas A, Constant SL, Bethony JM.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):115-24. PubMed ID: 15681140
    [Abstract] [Full Text] [Related]

  • 5. Molecular approaches to vaccinating against hookworm disease.
    Hotez PJ, Hawdon JM, Cappello M, Jones BF, Ghosh K, Volvovitz F, Xiao SH.
    Pediatr Res; 1996 Oct 01; 40(4):515-21. PubMed ID: 8888276
    [Abstract] [Full Text] [Related]

  • 6. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.
    Diemert DJ, Pinto AG, Freire J, Jariwala A, Santiago H, Hamilton RG, Periago MV, Loukas A, Tribolet L, Mulvenna J, Correa-Oliveira R, Hotez PJ, Bethony JM.
    J Allergy Clin Immunol; 2012 Jul 01; 130(1):169-76.e6. PubMed ID: 22633322
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Search for protective antigens of hookworms].
    Wiśniewski M, Długosz E, Baska P, Wedrychowicz H.
    Wiad Parazytol; 2006 Jul 01; 52(4):271-6. PubMed ID: 17432617
    [Abstract] [Full Text] [Related]

  • 11. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
    Hotez PJ, Bethony JM, Oliveira SC, Brindley PJ, Loukas A.
    Expert Rev Vaccines; 2008 Aug 01; 7(6):745-52. PubMed ID: 18665774
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ, Freire J, Valente V, Fraga CG, Talles F, Grahek S, Campbell D, Jariwala A, Periago MV, Enk M, Gazzinelli MF, Bottazzi ME, Hamilton R, Brelsford J, Yakovleva A, Li G, Peng J, Correa-Oliveira R, Hotez P, Bethony J.
    PLoS Negl Trop Dis; 2017 May 01; 11(5):e0005574. PubMed ID: 28464026
    [Abstract] [Full Text] [Related]

  • 13. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum.
    Mendez S, Zhan B, Goud G, Ghosh K, Dobardzic A, Wu W, Liu S, Deumic V, Dobardzic R, Liu Y, Bethony J, Hotez PJ.
    Vaccine; 2005 May 02; 23(24):3123-30. PubMed ID: 15837211
    [Abstract] [Full Text] [Related]

  • 14. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate.
    Curti E, Seid CA, Hudspeth E, Center L, Rezende W, Pollet J, Kwityn C, Hammond M, Matsunami RK, Engler DA, Hotez PJ, Elena Bottazzi M.
    Hum Vaccin Immunother; 2014 May 02; 10(7):1914-25. PubMed ID: 25424799
    [Abstract] [Full Text] [Related]

  • 15. Hookworm vaccines: past, present, and future.
    Loukas A, Bethony J, Brooker S, Hotez P.
    Lancet Infect Dis; 2006 Nov 02; 6(11):733-41. PubMed ID: 17067922
    [Abstract] [Full Text] [Related]

  • 16. Hookworm infection: Toward development of safe and effective peptide vaccines.
    Shalash AO, Hussein WM, Skwarczynski M, Toth I.
    J Allergy Clin Immunol; 2021 Dec 02; 148(6):1394-1419.e6. PubMed ID: 34872650
    [Abstract] [Full Text] [Related]

  • 17. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals.
    Bethony J, Loukas A, Smout M, Brooker S, Mendez S, Plieskatt J, Goud G, Bottazzi ME, Zhan B, Wang Y, Williamson A, Lustigman S, Correa-Oliveira R, Xiao S, Hotez PJ.
    FASEB J; 2005 Oct 02; 19(12):1743-5. PubMed ID: 16037096
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The immunoepidemiology of human hookworm infection.
    Quinnell RJ, Bethony J, Pritchard DI.
    Parasite Immunol; 2004 Oct 02; 26(11-12):443-54. PubMed ID: 15771680
    [Abstract] [Full Text] [Related]

  • 20. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74.
    Pearson MS, Jariwala AR, Abbenante G, Plieskatt J, Wilson D, Bottazzi ME, Hotez PJ, Keegan B, Bethony JM, Loukas A.
    Hum Vaccin Immunother; 2015 Oct 02; 11(5):1251-7. PubMed ID: 26018444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.